Document is current
Any future updates will be listed below
-
Authors
Klug, Lillian R. https://orcid.org/0000-0003-0520-8241
Khosroyani, Homma M. https://orcid.org/0000-0001-9709-6712
Kent, Jason D. https://orcid.org/0000-0001-7431-7877
Heinrich, Michael C. https://orcid.org/0000-0003-3790-0478
- License Information
-
More Information
Article History
Accepted: 8 February 2022
First Online: 25 February 2022
Competing interests
: M.C.H. has been a consultant for Blueprint Medicines, Deciphera Pharmaceuticals, Novartis and Theseus Pharmaceuticals, and has a patent for the treatment of GIST using imatinib that has been licensed by his institute to Novartis. The other authors declare no competing interests.
